Annual CFO
-$96.99 M
+$22.50 M+18.83%
December 31, 2022
Summary
- As of February 8, 2025, SPPI annual cash flow from operations is -$96.99 million, with the most recent change of +$22.50 million (+18.83%) on December 31, 2022.
- During the last 3 years, SPPI annual CFO has risen by +$37.64 million (+27.96%).
Performance
SPPI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$21.44 M
+$3.90 M+15.38%
March 31, 2023
Summary
- As of February 8, 2025, SPPI quarterly cash flow from operations is -$21.44 million, with the most recent change of +$3.90 million (+15.38%) on March 31, 2023.
- Over the past year, SPPI quarterly CFO has increased by +$8.86 million (+29.23%).
Performance
SPPI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$88.13 M
+$8.86 M+9.13%
March 31, 2023
Summary
- As of February 8, 2025, SPPI TTM cash flow from operations is -$88.13 million, with the most recent change of +$8.86 million (+9.13%) on March 31, 2023.
- Over the past year, SPPI TTM CFO has increased by +$27.16 million (+23.56%).
Performance
SPPI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SPPI Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.8% | +29.2% | +23.6% |
| 3 y3 years | +28.0% | +35.7% | +31.1% |
| 5 y5 years | -149.6% | +19.8% | +34.5% |
SPPI Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.2% | +19.7% | +41.5% | at high | +35.6% |
| 5 y | 5-year | at high | +38.8% | +19.7% | +60.9% | at high | +52.8% |
| alltime | all time | -234.8% | +38.8% | -174.9% | +86.8% | -201.8% | +52.8% |
Spectrum Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$21.44 M(-15.4%) | -$88.13 M(-9.1%) |
| Dec 2022 | -$96.99 M(-18.8%) | -$25.34 M(+41.5%) | -$96.99 M(-4.9%) |
| Sep 2022 | - | -$17.91 M(-23.6%) | -$102.00 M(-6.5%) |
| Jun 2022 | - | -$23.45 M(-22.6%) | -$109.09 M(-5.4%) |
| Mar 2022 | - | -$30.30 M(-0.2%) | -$115.29 M(-3.5%) |
| Dec 2021 | -$119.49 M(-1.8%) | -$30.35 M(+21.4%) | -$119.49 M(-2.4%) |
| Sep 2021 | - | -$25.00 M(-15.7%) | -$122.44 M(-2.3%) |
| Jun 2021 | - | -$29.65 M(-14.0%) | -$125.38 M(+2.1%) |
| Mar 2021 | - | -$34.49 M(+3.6%) | -$122.78 M(+0.9%) |
| Dec 2020 | -$121.63 M(-9.7%) | -$33.30 M(+19.2%) | -$121.63 M(+1.8%) |
| Sep 2020 | - | -$27.93 M(+3.3%) | -$119.52 M(+0.7%) |
| Jun 2020 | - | -$27.05 M(-18.9%) | -$118.67 M(-7.2%) |
| Mar 2020 | - | -$33.34 M(+6.9%) | -$127.92 M(-5.0%) |
| Dec 2019 | -$134.63 M(+115.7%) | -$31.19 M(+15.1%) | -$134.63 M(+16.3%) |
| Sep 2019 | - | -$27.09 M(-25.4%) | -$115.75 M(+16.3%) |
| Jun 2019 | - | -$36.29 M(-9.4%) | -$99.50 M(+31.4%) |
| Mar 2019 | - | -$40.05 M(+225.4%) | -$75.71 M(+21.3%) |
| Dec 2018 | -$62.40 M(+60.6%) | -$12.31 M(+13.5%) | -$62.40 M(-0.9%) |
| Sep 2018 | - | -$10.85 M(-13.2%) | -$62.99 M(+7.4%) |
| Jun 2018 | - | -$12.50 M(-53.3%) | -$58.65 M(+29.0%) |
| Mar 2018 | - | -$26.75 M(+107.4%) | -$45.47 M(+17.0%) |
| Dec 2017 | -$38.85 M(-4.0%) | -$12.90 M(+98.3%) | -$38.85 M(+32.5%) |
| Sep 2017 | - | -$6.50 M(-1066.3%) | -$29.32 M(-18.0%) |
| Jun 2017 | - | $673.00 K(-103.3%) | -$35.77 M(-33.1%) |
| Mar 2017 | - | -$20.13 M(+498.1%) | -$53.50 M(+32.2%) |
| Dec 2016 | -$40.46 M(-699.9%) | -$3.37 M(-74.0%) | -$40.46 M(+19.0%) |
| Sep 2016 | - | -$12.95 M(-24.1%) | -$33.99 M(+11.9%) |
| Jun 2016 | - | -$17.06 M(+140.9%) | -$30.39 M(-714.1%) |
| Mar 2016 | - | -$7.08 M(-328.4%) | $4.95 M(-26.6%) |
| Dec 2015 | $6.74 M(-285.9%) | $3.10 M(-133.2%) | $6.74 M(-54.0%) |
| Sep 2015 | - | -$9.35 M(-151.1%) | $14.66 M(-56.5%) |
| Jun 2015 | - | $18.27 M(-445.7%) | $33.69 M(+8.4%) |
| Mar 2015 | - | -$5.29 M(-148.0%) | $31.07 M(-956.8%) |
| Dec 2014 | -$3.63 M(+73.9%) | $11.02 M(+13.7%) | -$3.63 M(-46.1%) |
| Sep 2014 | - | $9.69 M(-38.1%) | -$6.72 M(-77.5%) |
| Jun 2014 | - | $15.66 M(-139.2%) | -$29.86 M(-53.1%) |
| Mar 2014 | - | -$39.99 M(-604.9%) | -$63.72 M(+2954.6%) |
| Dec 2013 | -$2.09 M(-102.9%) | $7.92 M(-158.9%) | -$2.09 M(+9.3%) |
| Sep 2013 | - | -$13.45 M(-26.1%) | -$1.91 M(-106.3%) |
| Jun 2013 | - | -$18.20 M(-184.1%) | $30.45 M(-54.3%) |
| Mar 2013 | - | $21.64 M(+167.3%) | $66.70 M(-7.3%) |
| Dec 2012 | $71.96 M(+66.2%) | $8.10 M(-57.2%) | $71.96 M(-3.8%) |
| Sep 2012 | - | $18.91 M(+4.8%) | $74.83 M(-1.5%) |
| Jun 2012 | - | $18.04 M(-32.9%) | $75.94 M(-12.2%) |
| Mar 2012 | - | $26.91 M(+145.4%) | $86.55 M(+99.9%) |
| Dec 2011 | $43.29 M(-292.0%) | $10.96 M(-45.3%) | $43.29 M(+1.6%) |
| Sep 2011 | - | $20.03 M(-30.1%) | $42.60 M(+122.5%) |
| Jun 2011 | - | $28.64 M(-275.2%) | $19.15 M(-248.7%) |
| Mar 2011 | - | -$16.35 M(-259.1%) | -$12.88 M(-42.9%) |
| Dec 2010 | -$22.54 M(+27.8%) | $10.28 M(-400.6%) | -$22.54 M(-48.0%) |
| Sep 2010 | - | -$3.42 M(+0.9%) | -$43.37 M(-15.5%) |
| Jun 2010 | - | -$3.39 M(-87.0%) | -$51.33 M(+16.7%) |
| Mar 2010 | - | -$26.01 M(+146.8%) | -$43.96 M(+149.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$17.63 M(+120.3%) | -$10.54 M(-7.4%) | -$17.63 M(+42.8%) |
| Sep 2009 | - | -$11.38 M(-386.4%) | -$12.35 M(+53.4%) |
| Jun 2009 | - | $3.97 M(+1161.6%) | -$8.05 M(+1305.2%) |
| Mar 2009 | - | $315.00 K(-106.0%) | -$573.00 K(-92.8%) |
| Dec 2008 | -$8.01 M(-68.5%) | -$5.26 M(-25.8%) | -$8.01 M(-37.1%) |
| Sep 2008 | - | -$7.08 M(-161.9%) | -$12.73 M(+18.1%) |
| Jun 2008 | - | $11.45 M(-260.9%) | -$10.78 M(-60.2%) |
| Mar 2008 | - | -$7.12 M(-28.7%) | -$27.07 M(+6.5%) |
| Dec 2007 | -$25.41 M(+88.0%) | -$9.98 M(+94.3%) | -$25.41 M(+62.2%) |
| Sep 2007 | - | -$5.14 M(+6.3%) | -$15.67 M(+4.9%) |
| Jun 2007 | - | -$4.83 M(-11.5%) | -$14.94 M(-2.6%) |
| Mar 2007 | - | -$5.46 M(+2223.8%) | -$15.33 M(+13.4%) |
| Dec 2006 | -$13.52 M(-15.7%) | -$235.00 K(-94.7%) | -$13.52 M(-25.8%) |
| Sep 2006 | - | -$4.41 M(-15.8%) | -$18.22 M(+4.0%) |
| Jun 2006 | - | -$5.23 M(+43.5%) | -$17.52 M(+6.1%) |
| Mar 2006 | - | -$3.65 M(-26.1%) | -$16.52 M(+3.0%) |
| Dec 2005 | -$16.05 M(+35.6%) | -$4.94 M(+33.0%) | -$16.05 M(+15.3%) |
| Sep 2005 | - | -$3.71 M(-12.3%) | -$13.91 M(+3.0%) |
| Jun 2005 | - | -$4.23 M(+33.6%) | -$13.51 M(+17.3%) |
| Mar 2005 | - | -$3.17 M(+13.0%) | -$11.51 M(-2.7%) |
| Dec 2004 | -$11.83 M(+78.7%) | -$2.80 M(-15.3%) | -$11.83 M(+17.4%) |
| Sep 2004 | - | -$3.31 M(+48.1%) | -$10.08 M(+11.6%) |
| Jun 2004 | - | -$2.23 M(-35.8%) | -$9.03 M(+3.2%) |
| Mar 2004 | - | -$3.48 M(+230.4%) | -$8.76 M(+32.3%) |
| Dec 2003 | -$6.62 M(-54.3%) | -$1.05 M(-53.4%) | -$6.62 M(+28.3%) |
| Sep 2003 | - | -$2.26 M(+15.5%) | -$5.16 M(-21.9%) |
| Jun 2003 | - | -$1.96 M(+45.4%) | -$6.60 M(-28.7%) |
| Mar 2003 | - | -$1.35 M(-431.9%) | -$9.27 M(-36.1%) |
| Dec 2002 | -$14.50 M(-41.6%) | $405.70 K(-111.0%) | -$14.50 M(-34.3%) |
| Sep 2002 | - | -$3.70 M(-19.8%) | -$22.08 M(-10.1%) |
| Jun 2002 | - | -$4.62 M(-29.8%) | -$24.55 M(-6.1%) |
| Mar 2002 | - | -$6.58 M(-8.4%) | -$26.14 M(+5.3%) |
| Dec 2001 | -$24.83 M(-42.3%) | -$7.18 M(+16.2%) | -$24.83 M(+14.2%) |
| Sep 2001 | - | -$6.18 M(-0.5%) | -$21.74 M(-36.7%) |
| Jun 2001 | - | -$6.21 M(+17.8%) | -$34.37 M(-12.5%) |
| Mar 2001 | - | -$5.27 M(+28.7%) | -$39.26 M(-8.8%) |
| Dec 2000 | -$43.03 M(+116.8%) | -$4.09 M(-78.2%) | -$43.03 M(-7.2%) |
| Sep 2000 | - | -$18.80 M(+69.4%) | -$46.39 M(+42.4%) |
| Jun 2000 | - | -$11.10 M(+22.8%) | -$32.58 M(+28.9%) |
| Mar 2000 | - | -$9.04 M(+21.4%) | -$25.28 M(+27.4%) |
| Dec 1999 | -$19.85 M(+90.8%) | -$7.45 M(+48.9%) | -$19.85 M(+26.4%) |
| Sep 1999 | - | -$5.00 M(+31.6%) | -$15.70 M(+16.3%) |
| Jun 1999 | - | -$3.80 M(+5.6%) | -$13.50 M(+16.4%) |
| Mar 1999 | - | -$3.60 M(+9.1%) | -$11.60 M(+11.5%) |
| Dec 1998 | -$10.40 M(+76.3%) | -$3.30 M(+17.9%) | -$10.40 M(+15.6%) |
| Sep 1998 | - | -$2.80 M(+47.4%) | -$9.00 M(+3.4%) |
| Jun 1998 | - | -$1.90 M(-20.8%) | -$8.70 M(+24.3%) |
| Mar 1998 | - | -$2.40 M(+26.3%) | -$7.00 M(+18.6%) |
| Dec 1997 | -$5.90 M(+391.7%) | -$1.90 M(-24.0%) | -$5.90 M(+47.5%) |
| Sep 1997 | - | -$2.50 M(+1150.0%) | -$4.00 M(+166.7%) |
| Jun 1997 | - | -$200.00 K(-84.6%) | -$1.50 M(+15.4%) |
| Mar 1997 | - | -$1.30 M | -$1.30 M |
| Dec 1996 | -$1.20 M | - | - |
FAQ
- What is Spectrum Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals annual CFO year-on-year change?
- What is Spectrum Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals quarterly CFO year-on-year change?
- What is Spectrum Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals TTM CFO year-on-year change?
What is Spectrum Pharmaceuticals annual cash flow from operations?
The current annual CFO of SPPI is -$96.99 M
What is the all time high annual CFO for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high annual cash flow from operations is $71.96 M
What is Spectrum Pharmaceuticals annual CFO year-on-year change?
Over the past year, SPPI annual cash flow from operations has changed by +$22.50 M (+18.83%)
What is Spectrum Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of SPPI is -$21.44 M
What is the all time high quarterly CFO for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high quarterly cash flow from operations is $28.64 M
What is Spectrum Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, SPPI quarterly cash flow from operations has changed by +$8.86 M (+29.23%)
What is Spectrum Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of SPPI is -$88.13 M
What is the all time high TTM CFO for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high TTM cash flow from operations is $86.55 M
What is Spectrum Pharmaceuticals TTM CFO year-on-year change?
Over the past year, SPPI TTM cash flow from operations has changed by +$27.16 M (+23.56%)